TPST Tempest Therapeutics, Inc.
Healthcare$1.86+2.76%ClosedMarket Cap: $8.3M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
24.74
P/S
0.00
EV/EBITDA
-0.33
DCF Value
$-0.34
FCF Yield
-319.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-729.9%
ROA
-401.0%
ROIC
-499.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-27.7M | $-27.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.1M | $-4.0M | $— | — |
| FY null | $0.00 | NaN% | $-26.6M | $-26.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.6M | $-3.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.0M | $-7.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-10.9M | $-10.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-13.9M | $-13.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-42.0M | $-41.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-10.6M | $-10.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.6M | $-9.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.0M | $-7.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-7.5M | $-7.5M | $-0.35 | — |